RecruitingPhase 2NCT04121780

Growth Hormone Replacement Therapy for Retried Professional Football Players

Interventional Study of Growth Hormone Replacement Therapy in Retired Professional Football Players With Growth Hormone Deficiency


Sponsor

Center for Neurological Studies

Enrollment

42 participants

Start Date

Oct 8, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 76 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Growth Hormone and Placebo for people with anterior pituitary hyposecretion syndrome, concussion, brain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 76 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALGrowth Hormone

Daily self-injections by subjects: 1-year double-blind phase; 6-month open-label extension for those who received placebo during the double-blind phase

OTHERPlacebo

Daily self-injections by subjects: 1-year double-blind phase


Locations(1)

Center for Neurolgoical Studies (CNS)

Dearborn, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04121780


Related Trials